NMPA Approval

Levetiracetam Concentrated Solution for Injection

Approval Number

国药准字H20213170

Company宝利化（南京）制药有限公司

Registration Date

March 9, 2021

Drug Information

Generic Name

左乙拉西坦注射用浓溶液

Dosage Form

注射剂

Strength

5ml:500mg

Drug Type

化学药品

Registration Date

March 9, 2021

Company Information

Applicant Company

Company Name宝利化（南京）制药有限公司

Company Address

南京经济技术开发区乌龙山路28号

Manufacturing Company

Company Name宝利化（南京）制药有限公司

Company Address

南京经济技术开发区乌龙山路28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.